Skip to main content
Cancer Explained

Disponible en español: Qué esperar de la terapia de células CAR T

Intermediate 7 min readSource verified

What to Expect With CAR T-Cell Therapy

A plain-language guide to CAR T-cell therapy and T-cell transfer therapy — how your own immune cells are changed in the lab to attack cancer, the steps involved, and side effects. Based on National Cancer Institute resources.

AI-assisted and source verified. Not reviewed by a healthcare professional unless specifically stated.

Sources last checked: 2026-07-14Last updated: 2026-07-14Next planned review: 2027-07-14

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status — Source verified. This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Our editorial processHow we use AIReport an error

NCI source

National Cancer Institute

The short answer

CAR T-cell therapy is a type of T-cell transfer therapy that changes your own immune cells in the lab so they can better attack cancer. Your cells are collected, grown over weeks, and given back through a vein. It can cause serious side effects such as cytokine release syndrome.

  • T-cell transfer therapy makes your own immune cells better able to attack cancer.

  • The two main types are TIL therapy and CAR T-cell therapy.

  • Your T cells are collected, changed or selected and grown in the lab, then given back through a vein.

  • Growing the cells can take 2 to 8 weeks, and you may have chemotherapy first.

Choose how you want to understand this

The full explanation.

The simple version

CAR T-cell therapy is a type of T-cell transfer therapy. T-cell transfer therapy is a kind of immunotherapy that makes your own immune cells better able to attack cancer. It is also called adoptive cell therapy, adoptive immunotherapy, and immune cell therapy.

Instead of giving you a drug, this treatment uses your own T cells — a type of immune cell — changed or selected in a lab to fight your cancer.

CAR T-cell therapy turns your own immune cells into better cancer fighters.

The basic steps

There are two main types of T-cell transfer therapy: TIL therapy and CAR T-cell therapy. Both share the same basic steps:

  1. Your own immune cells are collected.
  2. Large numbers of these cells are grown in the lab.
  3. The cells are given back to you through a needle in your vein.

Growing your T cells in the lab can take 2 to 8 weeks. During this time, you may have treatment with chemotherapy and maybe radiation therapy to get rid of other immune cells. Reducing your immune cells helps the transferred T cells work better. After these treatments, the lab-grown T cells are given back to you through a vein.

TIL therapy vs. CAR T-cell therapy

TIL therapy uses T cells called tumor-infiltrating lymphocytes that are found in your tumor. Doctors test these in the lab to find out which ones best recognize your tumor cells, then treat those selected cells so they grow to large numbers quickly. The idea is that these lymphocytes have already shown they can recognize your tumor, but there may not be enough of them — so giving you large numbers can help overcome that.

CAR T-cell therapy is similar to TIL therapy, but your T cells are changed in the lab so that they make a protein called CAR before they are grown and given back. CAR stands for chimeric antigen receptor. CARs are designed to let the T cells attach to specific proteins on the surface of cancer cells, improving their ability to attack.

Which cancers are treated

A TIL therapy called lifileucel has been approved by the FDA to treat melanoma. It has also shown promise in other cancers, such as certain cervical and bile duct cancers, but for those it is still experimental.

Six CAR T-cell therapies have been approved by the FDA for blood cancers. CAR T-cell therapy has also been studied for solid tumors, including breast and brain cancers, but that use is still experimental.

Side effects to know about

T-cell transfer therapy can cause side effects that people experience in different ways. What you may have and how serious it is depends on how healthy you are before treatment, your type of cancer, how advanced it is, the type of therapy, and the dose. Doctors and nurses cannot know for sure when or if side effects will occur, so it is important to know which signs to look for.

Cytokine release syndrome. CAR T-cell therapy can cause this serious side effect. It happens when the transferred T cells, or other immune cells responding to them, release a large amount of cytokines into the blood. Cytokines are immune substances with many functions, and a sudden increase can cause fever, nausea, headache, rash, rapid heartbeat, low blood pressure, and trouble breathing. Most people have a mild form, but in some it can be severe or life-threatening.

Recognizing normal cells. Although CAR T cells are designed to recognize proteins found only on cancer cells, they can sometimes recognize normal cells too. Depending on which normal cells are affected, this can cause a range of side effects, including organ damage.

Capillary leak syndrome. TIL therapy can cause this syndrome, where fluid and proteins leak out of tiny blood vessels into surrounding tissues, causing dangerously low blood pressure. It may lead to multiple organ failure and shock.

Because serious side effects are possible, your team will monitor you closely and needs to hear about new symptoms right away.

Words to know

Tap any term to see what it means.

Browse the full glossary →

Common questions

What is CAR T-cell therapy?

CAR T-cell therapy is a type of T-cell transfer therapy, which is a kind of immunotherapy that makes your own immune cells better able to attack cancer. In CAR T-cell therapy, your T cells are changed in the lab so they make a protein called CAR (chimeric antigen receptor) that helps them attach to and attack cancer cells.

How does the process work?

Both TIL and CAR T-cell therapy involve collecting your own immune cells, growing large numbers of them in the lab, and then giving them back to you through a needle in your vein. Growing the cells can take 2 to 8 weeks.

Why might I have chemotherapy before getting my cells back?

While your T cells are being grown in the lab, you may have chemotherapy and sometimes radiation to get rid of other immune cells. Reducing your immune cells helps the transferred T cells work better. After this, the lab-grown T cells are given back through a vein.

What is the difference between TIL and CAR T-cell therapy?

TIL therapy uses tumor-infiltrating lymphocytes found in your tumor; doctors select the ones that best recognize your tumor and grow them in large numbers. CAR T-cell therapy is similar, but your T cells are changed in the lab to make a CAR protein that helps them attach to specific proteins on cancer cells.

What cancers are treated with these therapies?

A TIL therapy has been approved to treat melanoma. Six CAR T-cell therapies have been approved for blood cancers. CAR T-cell therapy has also been studied for solid tumors such as breast and brain cancers, but that use is still experimental.

What serious side effects can happen?

CAR T-cell therapy can cause cytokine release syndrome, from a large release of immune substances called cytokines. Most people have a mild form, but it can be severe or life-threatening. CAR T cells can also sometimes recognize normal cells, causing side effects including organ damage. TIL therapy can cause capillary leak syndrome.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Quick quiz

Test your knowledge

0 of 4 answered

  1. Q1.According to this article, what does CAR T-cell therapy use to fight cancer?
  2. Q2.According to this article, how long can it take to grow the T cells in the lab?
  3. Q3.According to this article, what does CAR stand for?
  4. Q4.According to this article, what serious side effect can CAR T-cell therapy cause?

This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status: Source verified This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Related learning map

How this explanation connects to 15 other things you can explore — related topics, terms, questions, practice, and its NCI source.

What to Expect With CAR T-Cell Therapy